VIE Equity Snapshot
TKD Weekly Equity Report
Takeda Pharmaceutical Company Limited
What the company does
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba Fiber, Recombinate, Hemofil, Immunate, Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-licensing agreements with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and …
What the weekly tape is saying
TKD closed the latest completed week at 27.60 EUR. The 4-week return is -3.7% and the 12-week return is 140.7%. Trend Signal is active, Market Dynamics is 1.04. Setup signature: Risk-first tape with a 36/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- -29.20 EUR
- Vs Trend Line
- 194.5%
- Fair Value
- 255.0 EUR
- Vs Fair Value
- -89.2%
- 52W High
- 180.9 EUR
- 52W Low
- -70.44 EUR
- Drawdown
- -84.7%
- Range Position
- 39.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 8 weeks
- 52W Active Weeks
- 23
- 52W Active Breadth
- 44.2%
- Sector Scope
- AT Healthcare
- Sector Rank
- 22 of 112
- Sector Percentile
- 81.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 86 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 16
- 4W Rank
- 12 of 16
- Avg 1W
- -0.1%
- Avg 4W
- 0.6%
- Trend Breadth
- 56.3%
- Positive RS
- 25.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.04
- 4W MD Change
- -26.1%
- Relative Strength
- -27.01
- 4W RS Change
- 38.7%
- Expectation
- Negative
- Probability
- 42.40%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 0
- 13W Average
- 3
- 52W Average
- 16
- Vs 13W
- -
- Vs 52W
- -
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 39.5%
- 52W Volatility
- 27.6%
- Upside Weeks
- 20
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 9.0% / -6.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
- Market Cap
- 41.5B
Opportunity signals
- Trend Signal is active with a 8-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 27.60 EUR | 1.9% | -29.20 EUR | 255.0 EUR | 1.04 | -27.01 | 0 | On |
| 5 Jun 2026 | 27.08 EUR | -1.4% | -31.94 EUR | 301.6 EUR | 1.15 | -33.93 | 0 | On |
| 29 May 2026 | 27.46 EUR | -0.8% | -34.57 EUR | 349.4 EUR | 1.25 | -39.75 | 0 | On |
| 22 May 2026 | 27.67 EUR | -3.5% | -37.23 EUR | 396.5 EUR | 1.34 | -42.82 | 0 | On |
| 15 May 2026 | 28.67 EUR | 1.1% | -39.95 EUR | 444.0 EUR | 1.41 | -44.10 | 0 | On |
| 8 May 2026 | 28.35 EUR | -1.3% | -42.70 EUR | 491.1 EUR | 1.46 | -48.71 | 0 | On |
| 1 May 2026 | 28.71 EUR | 1.2% | -45.42 EUR | 539.2 EUR | 1.47 | -50.84 | 0 | On |
| 24 Apr 2026 | 28.36 EUR | -6.4% | -48.23 EUR | 587.4 EUR | 1.45 | -54.48 | 0 | On |
| 17 Apr 2026 | 30.29 EUR | -1.2% | -43.58 EUR | 635.8 EUR | 1.11 | -56.05 | 0 | Off |
| 10 Apr 2026 | 30.66 EUR | -4.7% | -38.81 EUR | 684.0 EUR | 0.78 | -57.19 | 0 | Off |
| 3 Apr 2026 | 32.16 EUR | 146.6% | -34.03 EUR | 732.3 EUR | 0.43 | -54.92 | 43 | Off |
| 27 Mar 2026 | -69.08 EUR | -1.9% | -29.21 EUR | 781.0 EUR | 0.12 | -194.38 | 0 | Off |
| 20 Mar 2026 | -67.78 EUR | 2.1% | -21.18 EUR | 829.4 EUR | 0.06 | -187.12 | 0 | Off |
| 13 Mar 2026 | -69.24 EUR | -1.7% | -13.00 EUR | 736.1 EUR | -0.00 | -200.57 | 0 | Off |